NasdaqCM - Delayed Quote USD

Avalo Therapeutics, Inc. (AVTX)

11.51 -1.59 (-12.14%)
At close: May 28 at 4:00 PM EDT
11.50 -0.01 (-0.09%)
After hours: May 28 at 6:20 PM EDT
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-26,830.00
-30,680.00
-26,751.00
-70,892.00
-40,539.00
--
Investing Cash Flow
356.00
-133.00
-95.00
-113.00
11,132.00
--
Financing Cash Flow
119,906.00
25,042.00
-14,699.00
106,762.00
44,784.00
--
End Cash Position
110,313.00
7,547.00
13,318.00
54,863.00
19,106.00
--
Income Tax Paid Supplemental Data
--
--
--
--
474.00
1,803.67
Interest Paid Supplemental Data
1,221.00
1,925.00
2,931.00
1,585.00
--
--
Capital Expenditure
--
--
-95.00
-113.00
-63.00
-262.01
Issuance of Capital Stock
148,096.00
46,219.00
34.00
71,929.00
44,452.00
--
Issuance of Debt
--
--
--
32,900.00
--
--
Repayment of Debt
--
-21,244.00
--
--
--
--
Repurchase of Capital Stock
--
--
-14,806.00
--
-93.87
-33.96
Free Cash Flow
-26,830.00
-30,680.00
-26,846.00
-71,005.00
-40,602.00
--
12/31/2019 - 10/14/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers